By creating clear colour contrast, the new fiber enables healthcare professionals to operate more accurately and efficiently, promoting greater safety and comfort for patients
Honeywell announced the expansion of its Spectra® Medical Grade (MG) Bio fiber portfolio with a blue-hued fiber that provides a strong visual aid to better differentiate between multiple suture sets in more complex surgeries. By creating clear colour contrast, the new fiber enables healthcare professionals to operate more accurately and efficiently, promoting greater safety and comfort for patients.
“We are providing major manufacturers the opportunity to modernise orthopaedic devices and improve surgical methods with our coloured Spectra MG Bio fiber, and to deliver that innovation in a collaborative, supportive manner,” said Abey Paul, business leader for Spectra MG Bio Fiber at Honeywell.
Engineered to be both ultra-lightweight and ultra-high strength, Honeywell’s Spectra MG Bio fiber provides superior resistance to chemicals, fatigue and abrasion when compared to conventional polyethylene fiber, making it an optimal solution for minimally invasive surgeries. Earlier this year, the technology received ISO 13485 certification, the highest management standard for the medical device industry.
The addition of a coloured variety to the Spectra MG Bio portfolio means the biomaterial can be utilised and trusted by a wide range of manufacturers building increasingly smaller, stronger and lighter devices. For the orthopaedic market, coloured Spectra MG Bio fiber provides new advantages for both existing devices and emerging trends used in corrective surgeries, such as robotics that reduce procedure durations and smart implants that flag dangerous bacterial presence. This advancement will help to support the growing worldwide market for orthopaedic devices, which is expected to reach a $43.1 billion value by 2024. In addition, by collaborating with and supplying directly to OEMs, Honeywell offers more tailored, flexible customer support to device manufacturers aiming to advance their equipment designs with coloured-fiber compatibility.
Honeywell’s new coloured Spectra MG Bio fiber is expected to be commercially available globally in Q3 2022, making the technology accessible to thriving orthopaedic device markets in regions including the US, EU, India, Asia Pacific and Latin America.
- Advertisement -